tiprankstipranks
Advertisement
Advertisement

SNTI Stock Latest News

Senti Biosciences Advances Proxy for Merger and CVR
Company AnnouncementsSenti Biosciences Advances Proxy for Merger and CVR
23h ago
8K
SNTI
VOO vs. VTI: Are You Owning the Wrong Vanguard ETF?
PremiumMarket News
VOO vs. VTI: Are You Owning the Wrong Vanguard ETF?
15d ago
MU
SPX
Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline
PremiumThe Fly
Senti Bio announces transaction to spin off Gene-Circuit-enabled pipeline
1M ago
SNTI
Senti Biosciences Details New Direct Financial Obligation
PremiumCompany Announcements
Senti Biosciences Details New Direct Financial Obligation
3M ago
8K
SNTI
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
PremiumCompany Announcements
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
3M ago
SNTI
Analyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
PremiumRatingsAnalyst Maintains Buy on Senti Biosciences, Keeps $12 Price Target on Strengthened Clinical, Regulatory, and Financial Position
3M ago
SNTI
Senti Bio completes Type B RMAT meeting with FDA on SENTI-202
Premium
The Fly
Senti Bio completes Type B RMAT meeting with FDA on SENTI-202
3M ago
SNTI
Senti Bio reports Q1 EPS (14c), consensus (36c)
Premium
The Fly
Senti Bio reports Q1 EPS (14c), consensus (36c)
3M ago
SNTI
Senti Biosciences Advances SENTI-202 With New FDA Support
PremiumCompany Announcements
Senti Biosciences Advances SENTI-202 With New FDA Support
3M ago
8K
SNTI
Senti Biosciences Secures Convertible Note Financing with Celadon
PremiumCompany Announcements
Senti Biosciences Secures Convertible Note Financing with Celadon
4M ago
8K
SNTI
Senti Biosciences Plans Tax-Free Holding Company Reorganization
PremiumCompany Announcements
Senti Biosciences Plans Tax-Free Holding Company Reorganization
5M ago
8K
SNTI
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
PremiumRatings
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
5M ago
SNTI
Senti Bio reports Q4 EPS (53c), consensus (47c)
PremiumThe FlySenti Bio reports Q4 EPS (53c), consensus (47c)
5M ago
SNTI
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
Premium
Company Announcements
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
5M ago
8K
SNTI
Senti Bio completes enrollment in Phase 1 trial of SENTI-202
Premium
The Fly
Senti Bio completes enrollment in Phase 1 trial of SENTI-202
6M ago
SNTI
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
PremiumRatings
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
8M ago
SNTI
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
PremiumRatings
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
8M ago
SNTI
Senti Bio price target raised to $13 from $12 at Chardan
PremiumThe Fly
Senti Bio price target raised to $13 from $12 at Chardan
9M ago
SNTI
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
9M ago
HD
LE
Why Is Senti Biosciences Stock (SNTI) Up Today?
PremiumMarket NewsWhy Is Senti Biosciences Stock (SNTI) Up Today?
9M ago
SNTI
Senti Biosciences Reports Promising Phase 1 Trial Results
Premium
Company Announcements
Senti Biosciences Reports Promising Phase 1 Trial Results
9M ago
8K
SNTI
Senti Bio receives FDA RMAT designation for SENTI-202
Premium
The Fly
Senti Bio receives FDA RMAT designation for SENTI-202
9M ago
SNTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >